Insider · CIK 0001786304
John M. Evans
ceoofficerdirector
Files at BEAM (Beam Therapeutics Inc.). First filing Feb 3, 2025, latest Feb 2, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 4
$0 bought, $4.0M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
BEAM: Beam Therapeutics Inc.
BEAMOct 9, 2026 · close 25.70
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | Beam Therapeutics Inc. | $1.4M 50,000 shares | -5% | +101% from low-17% from high | |
| 30Weak | Beam Therapeutics Inc. | $1.2M 50,000 shares | -5% | +66% from low-29% from high | |
| 39Weak | Beam Therapeutics Inc. | $563k 30,663 shares | -3% | 0% from low-48% from high | |
| 27Weak | Beam Therapeutics Inc. | $802k 30,000 shares | -3% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 29, 2026 | BEAM Beam Therapeutics Inc. | MOption exercise Common Stock10b5-1 | +19,336 | $0.67 | $13k | 1,006,003 | Feb 2, 2026 |
| Jan 29, 2026 | BEAM Beam Therapeutics Inc. | MOption exercise Common Stock10b5-1 | +5,664 | $0.67 | $3,795 | 1,011,667 | Feb 2, 2026 |
| Jan 29, 2026 | BEAM Beam Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -16,333 | $29.19 | $477k | 995,334 | Feb 2, 2026 |
| Jan 29, 2026 | BEAM Beam Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -8,667 | $29.74 | $258k | 986,667 | Feb 2, 2026 |
| Jan 30, 2026 | BEAM Beam Therapeutics Inc. | MOption exercise Common Stock10b5-1 | +25,000 | $0.67 | $17k | 1,011,667 | Feb 2, 2026 |
| Jan 30, 2026 | BEAM Beam Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -22,094 | $28.27 | $625k | 989,573 | Feb 2, 2026 |
| Jan 30, 2026 | BEAM Beam Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -2,906 | $29.00 | $84k | 986,667 | Feb 2, 2026 |
| Jan 29, 2026 | BEAM Beam Therapeutics Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -19,336 | $0.00 | $0 | 0 | Feb 2, 2026 |
| Jan 29, 2026 | BEAM Beam Therapeutics Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -5,664 | $0.00 | $0 | 93,672 | Feb 2, 2026 |
| Jan 30, 2026 | BEAM Beam Therapeutics Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -25,000 | $0.00 | $0 | 68,672 | Feb 2, 2026 |
| Jan 31, 2026 | BEAM Beam Therapeutics Inc. | AGrant or award Stock Option (Right to Buy)derivative10b5-1 | +180,000 | $0.00 | $0 | 180,000 | Feb 2, 2026 |
| Oct 1, 2025 | BEAM Beam Therapeutics Inc. | MOption exercise Common Stock10b5-1 | +25,000 | $0.67 | $17k | 1,011,667 | Oct 3, 2025 |
| Oct 1, 2025 | BEAM Beam Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -25,000 | $24.51 | $613k | 986,667 | Oct 3, 2025 |
| Oct 2, 2025 | BEAM Beam Therapeutics Inc. | MOption exercise Common Stock10b5-1 | +25,000 | $0.67 | $17k | 1,011,667 | Oct 3, 2025 |
| Oct 2, 2025 | BEAM Beam Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -25,000 | $24.63 | $616k | 986,667 | Oct 3, 2025 |
| Oct 1, 2025 | BEAM Beam Therapeutics Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -25,000 | $0.00 | $0 | 44,336 | Oct 3, 2025 |
| Oct 2, 2025 | BEAM Beam Therapeutics Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -25,000 | $0.00 | $0 | 19,336 | Oct 3, 2025 |
| Apr 1, 2025 | BEAM Beam Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -30,663 | $18.35 | $563k | 986,249 | Apr 3, 2025 |
| Mar 31, 2025 | BEAM Beam Therapeutics Inc. | AGrant or award Common Stock | +77,500 | $0.00 | $0 | 1,016,159 | Apr 2, 2025 |
| Jan 30, 2025 | BEAM Beam Therapeutics Inc. | MOption exercise Common Stock10b5-1 | +30,000 | $0.67 | $20k | 968,659 | Apr 2, 2025 |
| Jan 30, 2025 | BEAM Beam Therapeutics Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -30,000 | $0.00 | $0 | 69,336 | Apr 2, 2025 |
| Jan 30, 2025 | BEAM Beam Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -29,800 | $26.75 | $797k | 908,859 | Feb 3, 2025 |
| Jan 30, 2025 | BEAM Beam Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -200 | $27.28 | $5,456 | 908,659 | Feb 3, 2025 |
| Jan 31, 2025 | BEAM Beam Therapeutics Inc. | AGrant or award Stock Option (Right to Buy)derivative10b5-1 | +155,000 | $0.00 | $0 | 155,000 | Feb 3, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.